argenx is a startup based in the Netherlands, most recent round Pre-ipo, 2 tracked investors.
argenx is a startup based in the Netherlands. Its most recent tracked round is Pre-ipo. Brouky records 2 investors associated with the company.
argenx SE is a biopharmaceutical company based in the Netherlands that develops differentiated antibody therapeutics for the treatment of severe autoimmune diseases using its discovery platform, Simple Antibody.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.